Organigram Global (OGI) Cash & Equivalents (2018 - 2026)

Organigram Global (OGI) has 8 years of Cash & Equivalents data on file, last reported at $61.0 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $61.0 million, down 34.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.0 million (down 34.04% YoY), and the FY2025 annual result was $5.4 million, changed N/A from the prior year.
• Cash & Equivalents advanced to $61.0 million in Q1 2026 per OGI's latest filing, from $5.4 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $97.2 million in Q3 2024 and troughed at $5.4 million in Q4 2025.
• A 4-year average of $58.6 million and a median of $61.0 million in 2026 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents surged 151.78% in 2024, then sank 94.28% in 2025.
• A 4-year view of Cash & Equivalents shows it stood at $38.6 million in 2023, then soared by 145.87% to $94.9 million in 2024, then slumped by 94.28% to $5.4 million in 2025, then jumped by 1022.05% to $61.0 million in 2026.
• Business Quant data shows OGI's Cash & Equivalents at $61.0 million in Q1 2026, $5.4 million in Q4 2025, and $20.5 million in Q3 2025.